2022 COVID-19 Regulatory Impact Follow-up Survey Whitepaper (Summer 2022)
Introduction
In the spring of 2022, we followed up on our 2020 Covid-19 Regulatory Impact research to see how regulatory organizations were evolving with the ongoing pandemic. In our original study, conducted 6 months into the pandemic, we learned how companies tapped into their organizational agility and resiliency as they were forced to quickly shift and adapt to a socially distanced and virtual world. It enabled them to rethink “time to change” preconceptions and endure industry wide challenges while making significant RIM investments in global capabilities.
This white paper provides insights from the 2022 follow-up pulse study, explores our viewpoint on how organizations continue evolving throughout the pandemic while highlighting what strategies and implementations were adopted and the shifting norms of company culture and ways of working. We also review the study results alongside our findings from our 2022 World Class Regulatory Information Management RIM℠ study to better understand how key trends and priorities are being affected. Key study take-aways we explore in this paper include:
- Shifts in strategies and priorities in the regulatory organization
- The impact of pandemic on working relationships with health authorities
- The evolution of relationships between sponsors and providers
Planned vs. actual implementations in the past 12-18 months
Evolution of Team Effectiveness with new ways of working